Bio-Rad Laboratories, Inc.
BIO
NYSE
Health Technology
Medical Specialties
305.96
USD
+4.26
+1.41%
Закрыт: 07-22 20:00 (UTC+0)
305.96
USD
+1.34
+0.44%
До открытия рынка: 07-23 08:26 (UTC+0)

BIO Ключевая статистика

Максимум
307.10
Открыть
301.00
Объем
275.06K
Минимум
298.74
Предыдущее закрытие
301.70
Объем торгов
84.03M
Макс. 52 нед.
343.12
Отн. объем
0.897
Амплитуда (%)
2.77%
Мин. 52 нед.
236.73
Коэф. оборота
1.27%
Рыночная капитализация
8.18B
P/E (TTM)
50.37
P/E (год.)
10.978
P/B
1.2
P/S
3.16
Прибыль на акцию (EPS)
6.075
Дивиденд (TTM)
0
Дивидендная доходность
0.00%
Акции в обращении
21.70M
Валюта
USD

BIO Доходность цены

7 день
30 день
90 день
180 день
С начала года
1 Год
BIO Распределение денежных потоков
BIO Дневной объем коротких продаж
BIO История short interest
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.18B, with a P/E ratio of 50.37. On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO ближе к верхней границе its most recent trading range. Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is примерно соответствует обычному уровню than usual. Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
Название компании
Bio-Rad Laboratories, Inc.
Сектор
Health Technology
Отрасль
Medical Specialties
Биржи
NYSE
Количество сотрудников
7,450
Размер лота
40
Официальный сайт
Валюта
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

BIO FAQ

Поиск
Ещё